Transcription factor expression and hormone production in pancreatic AR42J cells
AR42J is an exocrine pancreatic cell line that has been reported to differentiate towards an endocrine phenotype when stimulated with various growth factors, such as activin A, hepatocyte growth factor (HGF), betacellulin or glucagon-like peptide 1. In our experiments, AR42J-B13 cells differentiated...
Gespeichert in:
Veröffentlicht in: | Molecular and cellular endocrinology 2000-07, Vol.165 (1), p.41-49 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 49 |
---|---|
container_issue | 1 |
container_start_page | 41 |
container_title | Molecular and cellular endocrinology |
container_volume | 165 |
creator | Palgi, Jaan Stumpf, Erik Otonkoski, Timo |
description | AR42J is an exocrine pancreatic cell line that has been reported to differentiate towards an endocrine phenotype when stimulated with various growth factors, such as activin A, hepatocyte growth factor (HGF), betacellulin or glucagon-like peptide 1. In our experiments, AR42J-B13 cells differentiated morphologically in response to the growth factor treatment as reported previously. However, they failed to express the insulin gene. We found that the cells did not express several transcription factors known to be found in the β-cell, including Nkx6.1, isl-1, Pax4 and Pax6. In addition, the mRNA level for pdx-1 and Nkx2.2 were very low in comparison to the insulinoma cell lines INS-1 and RINm5F. However, some transcription factors typically found in β-cells and neuroendocrine cells were expressed also in the AR42J-B13 cells. These included BETA2/NeuroD, HNF1α, C/EBPβ and IA-1. Unlike the insulinoma cells, AR42J cells expressed the exocrine transcription factor p48. In order to induce endocrine differentiation, we transfected the AR42J-B13 cells with the full length cDNAs of isl-1, Nkx6.1, Nkx2.2 and pdx-1 under the control of the CMV promoter, both separately and in combinations. The expression of Nkx2.2 led consistently to the appearance of pancreatic polypeptide but not insulin, glucagon or somatostatin mRNA. The PP mRNA expression in Nkx2.2 cDNA transfected cells was independent of the growth factor treatment used for differentiating AR42J cells. In conclusion, the AR42J-B13 line possesses some features of a pancreatic neuroendocrine cell. However, we were unable to confirm the capacity of these cells to differentiate into insulin-producing cells. Our results indicate that Nkx2.2 plays a role in the transcriptional regulation of PP expression. |
doi_str_mv | 10.1016/S0303-7207(00)00265-3 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71767006</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0303720700002653</els_id><sourcerecordid>71767006</sourcerecordid><originalsourceid>FETCH-LOGICAL-c427t-c9892162d83360ca3eea39d0eceddbec4e737493ba4a82d900f7e074244c227c3</originalsourceid><addsrcrecordid>eNqFkMtKw0AUhgdRbK0-gpKV6CJ65pJMspJSvFJQtK6H6cwJjjQXZxLRtzdpi7hzdeDwncv_EXJM4YICTS9fgAOPJQN5BnAOwNIk5jtkTDPJ4gwSuUvGv8iIHITwDgAyYdk-GVHIBYiMjcnTwusqGO-a1tVVVGjT1j7Cr8ZjCENHVzZ6q31ZVxg1vradWYOuihpdGY-6dSaaPgv2EBlcrcIh2Sv0KuDRtk7I6831YnYXzx9v72fTeWwEk21s8ixnNGU24zwFozmi5rkFNGjtEo1AyaXI-VILnTGbAxQSQQomhGFMGj4hp5u9_VMfHYZWlS4MH-gK6y4oSWUqAdIeTDag8XUIHgvVeFdq_60oqEGlWqtUgycFoNYqFe_nTrYHumWJ9s_Uxl0PXG0A7GN-OvQqGIdVH8B5NK2ytfvnxA_bXoNk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71767006</pqid></control><display><type>article</type><title>Transcription factor expression and hormone production in pancreatic AR42J cells</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Palgi, Jaan ; Stumpf, Erik ; Otonkoski, Timo</creator><creatorcontrib>Palgi, Jaan ; Stumpf, Erik ; Otonkoski, Timo</creatorcontrib><description>AR42J is an exocrine pancreatic cell line that has been reported to differentiate towards an endocrine phenotype when stimulated with various growth factors, such as activin A, hepatocyte growth factor (HGF), betacellulin or glucagon-like peptide 1. In our experiments, AR42J-B13 cells differentiated morphologically in response to the growth factor treatment as reported previously. However, they failed to express the insulin gene. We found that the cells did not express several transcription factors known to be found in the β-cell, including Nkx6.1, isl-1, Pax4 and Pax6. In addition, the mRNA level for pdx-1 and Nkx2.2 were very low in comparison to the insulinoma cell lines INS-1 and RINm5F. However, some transcription factors typically found in β-cells and neuroendocrine cells were expressed also in the AR42J-B13 cells. These included BETA2/NeuroD, HNF1α, C/EBPβ and IA-1. Unlike the insulinoma cells, AR42J cells expressed the exocrine transcription factor p48. In order to induce endocrine differentiation, we transfected the AR42J-B13 cells with the full length cDNAs of isl-1, Nkx6.1, Nkx2.2 and pdx-1 under the control of the CMV promoter, both separately and in combinations. The expression of Nkx2.2 led consistently to the appearance of pancreatic polypeptide but not insulin, glucagon or somatostatin mRNA. The PP mRNA expression in Nkx2.2 cDNA transfected cells was independent of the growth factor treatment used for differentiating AR42J cells. In conclusion, the AR42J-B13 line possesses some features of a pancreatic neuroendocrine cell. However, we were unable to confirm the capacity of these cells to differentiate into insulin-producing cells. Our results indicate that Nkx2.2 plays a role in the transcriptional regulation of PP expression.</description><identifier>ISSN: 0303-7207</identifier><identifier>EISSN: 1872-8057</identifier><identifier>DOI: 10.1016/S0303-7207(00)00265-3</identifier><identifier>PMID: 10940482</identifier><language>eng</language><publisher>Ireland: Elsevier Ireland Ltd</publisher><subject>Activins ; Animals ; AR42J cells ; Base Sequence ; Cell Differentiation - drug effects ; Cell Line ; DNA Primers - genetics ; DNA, Complementary - genetics ; Gene Expression - drug effects ; Glucagon - biosynthesis ; Glucagon - genetics ; Hepatocyte Growth Factor - pharmacology ; Hormones - biosynthesis ; Hormones - genetics ; Inhibins - pharmacology ; Insulin ; Insulin - biosynthesis ; Insulin - genetics ; Pancreas - cytology ; Pancreas - drug effects ; Pancreas - metabolism ; Pancreatic Polypeptide - biosynthesis ; Pancreatic Polypeptide - genetics ; Rats ; RNA, Messenger - genetics ; RNA, Messenger - metabolism ; Somatostatin - biosynthesis ; Somatostatin - genetics ; Transcription factor ; Transcription Factors - genetics ; Transfection</subject><ispartof>Molecular and cellular endocrinology, 2000-07, Vol.165 (1), p.41-49</ispartof><rights>2000 Elsevier Science Ireland Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c427t-c9892162d83360ca3eea39d0eceddbec4e737493ba4a82d900f7e074244c227c3</citedby><cites>FETCH-LOGICAL-c427t-c9892162d83360ca3eea39d0eceddbec4e737493ba4a82d900f7e074244c227c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0303-7207(00)00265-3$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,778,782,3539,27907,27908,45978</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10940482$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Palgi, Jaan</creatorcontrib><creatorcontrib>Stumpf, Erik</creatorcontrib><creatorcontrib>Otonkoski, Timo</creatorcontrib><title>Transcription factor expression and hormone production in pancreatic AR42J cells</title><title>Molecular and cellular endocrinology</title><addtitle>Mol Cell Endocrinol</addtitle><description>AR42J is an exocrine pancreatic cell line that has been reported to differentiate towards an endocrine phenotype when stimulated with various growth factors, such as activin A, hepatocyte growth factor (HGF), betacellulin or glucagon-like peptide 1. In our experiments, AR42J-B13 cells differentiated morphologically in response to the growth factor treatment as reported previously. However, they failed to express the insulin gene. We found that the cells did not express several transcription factors known to be found in the β-cell, including Nkx6.1, isl-1, Pax4 and Pax6. In addition, the mRNA level for pdx-1 and Nkx2.2 were very low in comparison to the insulinoma cell lines INS-1 and RINm5F. However, some transcription factors typically found in β-cells and neuroendocrine cells were expressed also in the AR42J-B13 cells. These included BETA2/NeuroD, HNF1α, C/EBPβ and IA-1. Unlike the insulinoma cells, AR42J cells expressed the exocrine transcription factor p48. In order to induce endocrine differentiation, we transfected the AR42J-B13 cells with the full length cDNAs of isl-1, Nkx6.1, Nkx2.2 and pdx-1 under the control of the CMV promoter, both separately and in combinations. The expression of Nkx2.2 led consistently to the appearance of pancreatic polypeptide but not insulin, glucagon or somatostatin mRNA. The PP mRNA expression in Nkx2.2 cDNA transfected cells was independent of the growth factor treatment used for differentiating AR42J cells. In conclusion, the AR42J-B13 line possesses some features of a pancreatic neuroendocrine cell. However, we were unable to confirm the capacity of these cells to differentiate into insulin-producing cells. Our results indicate that Nkx2.2 plays a role in the transcriptional regulation of PP expression.</description><subject>Activins</subject><subject>Animals</subject><subject>AR42J cells</subject><subject>Base Sequence</subject><subject>Cell Differentiation - drug effects</subject><subject>Cell Line</subject><subject>DNA Primers - genetics</subject><subject>DNA, Complementary - genetics</subject><subject>Gene Expression - drug effects</subject><subject>Glucagon - biosynthesis</subject><subject>Glucagon - genetics</subject><subject>Hepatocyte Growth Factor - pharmacology</subject><subject>Hormones - biosynthesis</subject><subject>Hormones - genetics</subject><subject>Inhibins - pharmacology</subject><subject>Insulin</subject><subject>Insulin - biosynthesis</subject><subject>Insulin - genetics</subject><subject>Pancreas - cytology</subject><subject>Pancreas - drug effects</subject><subject>Pancreas - metabolism</subject><subject>Pancreatic Polypeptide - biosynthesis</subject><subject>Pancreatic Polypeptide - genetics</subject><subject>Rats</subject><subject>RNA, Messenger - genetics</subject><subject>RNA, Messenger - metabolism</subject><subject>Somatostatin - biosynthesis</subject><subject>Somatostatin - genetics</subject><subject>Transcription factor</subject><subject>Transcription Factors - genetics</subject><subject>Transfection</subject><issn>0303-7207</issn><issn>1872-8057</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMtKw0AUhgdRbK0-gpKV6CJ65pJMspJSvFJQtK6H6cwJjjQXZxLRtzdpi7hzdeDwncv_EXJM4YICTS9fgAOPJQN5BnAOwNIk5jtkTDPJ4gwSuUvGv8iIHITwDgAyYdk-GVHIBYiMjcnTwusqGO-a1tVVVGjT1j7Cr8ZjCENHVzZ6q31ZVxg1vradWYOuihpdGY-6dSaaPgv2EBlcrcIh2Sv0KuDRtk7I6831YnYXzx9v72fTeWwEk21s8ixnNGU24zwFozmi5rkFNGjtEo1AyaXI-VILnTGbAxQSQQomhGFMGj4hp5u9_VMfHYZWlS4MH-gK6y4oSWUqAdIeTDag8XUIHgvVeFdq_60oqEGlWqtUgycFoNYqFe_nTrYHumWJ9s_Uxl0PXG0A7GN-OvQqGIdVH8B5NK2ytfvnxA_bXoNk</recordid><startdate>20000725</startdate><enddate>20000725</enddate><creator>Palgi, Jaan</creator><creator>Stumpf, Erik</creator><creator>Otonkoski, Timo</creator><general>Elsevier Ireland Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20000725</creationdate><title>Transcription factor expression and hormone production in pancreatic AR42J cells</title><author>Palgi, Jaan ; Stumpf, Erik ; Otonkoski, Timo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c427t-c9892162d83360ca3eea39d0eceddbec4e737493ba4a82d900f7e074244c227c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Activins</topic><topic>Animals</topic><topic>AR42J cells</topic><topic>Base Sequence</topic><topic>Cell Differentiation - drug effects</topic><topic>Cell Line</topic><topic>DNA Primers - genetics</topic><topic>DNA, Complementary - genetics</topic><topic>Gene Expression - drug effects</topic><topic>Glucagon - biosynthesis</topic><topic>Glucagon - genetics</topic><topic>Hepatocyte Growth Factor - pharmacology</topic><topic>Hormones - biosynthesis</topic><topic>Hormones - genetics</topic><topic>Inhibins - pharmacology</topic><topic>Insulin</topic><topic>Insulin - biosynthesis</topic><topic>Insulin - genetics</topic><topic>Pancreas - cytology</topic><topic>Pancreas - drug effects</topic><topic>Pancreas - metabolism</topic><topic>Pancreatic Polypeptide - biosynthesis</topic><topic>Pancreatic Polypeptide - genetics</topic><topic>Rats</topic><topic>RNA, Messenger - genetics</topic><topic>RNA, Messenger - metabolism</topic><topic>Somatostatin - biosynthesis</topic><topic>Somatostatin - genetics</topic><topic>Transcription factor</topic><topic>Transcription Factors - genetics</topic><topic>Transfection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Palgi, Jaan</creatorcontrib><creatorcontrib>Stumpf, Erik</creatorcontrib><creatorcontrib>Otonkoski, Timo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Molecular and cellular endocrinology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Palgi, Jaan</au><au>Stumpf, Erik</au><au>Otonkoski, Timo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transcription factor expression and hormone production in pancreatic AR42J cells</atitle><jtitle>Molecular and cellular endocrinology</jtitle><addtitle>Mol Cell Endocrinol</addtitle><date>2000-07-25</date><risdate>2000</risdate><volume>165</volume><issue>1</issue><spage>41</spage><epage>49</epage><pages>41-49</pages><issn>0303-7207</issn><eissn>1872-8057</eissn><abstract>AR42J is an exocrine pancreatic cell line that has been reported to differentiate towards an endocrine phenotype when stimulated with various growth factors, such as activin A, hepatocyte growth factor (HGF), betacellulin or glucagon-like peptide 1. In our experiments, AR42J-B13 cells differentiated morphologically in response to the growth factor treatment as reported previously. However, they failed to express the insulin gene. We found that the cells did not express several transcription factors known to be found in the β-cell, including Nkx6.1, isl-1, Pax4 and Pax6. In addition, the mRNA level for pdx-1 and Nkx2.2 were very low in comparison to the insulinoma cell lines INS-1 and RINm5F. However, some transcription factors typically found in β-cells and neuroendocrine cells were expressed also in the AR42J-B13 cells. These included BETA2/NeuroD, HNF1α, C/EBPβ and IA-1. Unlike the insulinoma cells, AR42J cells expressed the exocrine transcription factor p48. In order to induce endocrine differentiation, we transfected the AR42J-B13 cells with the full length cDNAs of isl-1, Nkx6.1, Nkx2.2 and pdx-1 under the control of the CMV promoter, both separately and in combinations. The expression of Nkx2.2 led consistently to the appearance of pancreatic polypeptide but not insulin, glucagon or somatostatin mRNA. The PP mRNA expression in Nkx2.2 cDNA transfected cells was independent of the growth factor treatment used for differentiating AR42J cells. In conclusion, the AR42J-B13 line possesses some features of a pancreatic neuroendocrine cell. However, we were unable to confirm the capacity of these cells to differentiate into insulin-producing cells. Our results indicate that Nkx2.2 plays a role in the transcriptional regulation of PP expression.</abstract><cop>Ireland</cop><pub>Elsevier Ireland Ltd</pub><pmid>10940482</pmid><doi>10.1016/S0303-7207(00)00265-3</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0303-7207 |
ispartof | Molecular and cellular endocrinology, 2000-07, Vol.165 (1), p.41-49 |
issn | 0303-7207 1872-8057 |
language | eng |
recordid | cdi_proquest_miscellaneous_71767006 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Activins Animals AR42J cells Base Sequence Cell Differentiation - drug effects Cell Line DNA Primers - genetics DNA, Complementary - genetics Gene Expression - drug effects Glucagon - biosynthesis Glucagon - genetics Hepatocyte Growth Factor - pharmacology Hormones - biosynthesis Hormones - genetics Inhibins - pharmacology Insulin Insulin - biosynthesis Insulin - genetics Pancreas - cytology Pancreas - drug effects Pancreas - metabolism Pancreatic Polypeptide - biosynthesis Pancreatic Polypeptide - genetics Rats RNA, Messenger - genetics RNA, Messenger - metabolism Somatostatin - biosynthesis Somatostatin - genetics Transcription factor Transcription Factors - genetics Transfection |
title | Transcription factor expression and hormone production in pancreatic AR42J cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T21%3A00%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transcription%20factor%20expression%20and%20hormone%20production%20in%20pancreatic%20AR42J%20cells&rft.jtitle=Molecular%20and%20cellular%20endocrinology&rft.au=Palgi,%20Jaan&rft.date=2000-07-25&rft.volume=165&rft.issue=1&rft.spage=41&rft.epage=49&rft.pages=41-49&rft.issn=0303-7207&rft.eissn=1872-8057&rft_id=info:doi/10.1016/S0303-7207(00)00265-3&rft_dat=%3Cproquest_cross%3E71767006%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71767006&rft_id=info:pmid/10940482&rft_els_id=S0303720700002653&rfr_iscdi=true |